Showing posts with label Rotavirus. Show all posts
Showing posts with label Rotavirus. Show all posts

Thursday, March 21, 2013

CDC: Norovirus Now Leading Cause Of Gastroenteritis In Children

 

norovirus 3D structure

Norovirus – Credit HPA

 

# 7020

 

Prior to the introduction of a pair of live, attenuated  Rotavirus vaccines in the middle of the last decade (RotaTeq and Rotarix), nearly all children in the United States were infected by one of the Rotaviruses before their 5th birthday (cite). 

 

The CDC estimated the pre-vaccine disease burden in the United States each year as:

 

• more than 400,000 doctor visits,
• more than 200,000 emergency room visits,
• 55,000 to 70,000 hospitalizations, and
• 20-60 deaths

 

With the introduction of the Rotavirus vaccine in 2006, the number youngsters needing emergency department care or hospitalization due to the Rotavirus had dropped by about 85% by 2010 (cite).

 

As the number of Rotavirus cases begins to go down, it is not terribly surprising to find a new king of the stomach virus hill among children.

 

From a study just published in the New England Journal of Medicine, we learn that Norovirus has now taken the lead as the number one cause of gastroenteritis in children in the United States.

 

Special Article

Norovirus and Medically Attended Gastroenteritis in U.S. Children

Daniel C. Payne, Ph.D., M.S.P.H., Jan Vinjé, Ph.D., Peter G. Szilagyi, M.D., M.P.H., Kathryn M. Edwards, M.D., Mary Allen Staat, M.D., M.P.H., Geoffrey A. Weinberg, M.D., Caroline B. Hall, M.D., James Chappell, M.D., Ph.D., David I. Bernstein, M.D., Aaron T. Curns, M.P.H., Mary Wikswo, M.P.H., S. Hannah Shirley, B.S. , Aron J. Hall, D.V.M., M.S.P.H., Benjamin Lopman, Ph.D., M.P.H., and Umesh D. Parashar, M.B., B.S., M.P.H.

N Engl J Med 2013; 368:1121-1130

March 21, 2013 DOI: 10.1056/NEJMsa1206589

<SNIP>

Conclusions

Since the introduction of rotavirus vaccines, norovirus has become the leading cause of medically attended acute gastroenteritis in U.S. children and is associated with nearly 1 million health care visits annually. (Funded by the Centers for Disease Control and Prevention.)

 

For some more background on this CDC-funded study, we go to the CDC Newsroom.

 

Norovirus is now the leading cause of severe gastroenteritis in US children

Norovirus is now the leading cause of acute gastroenteritis among children less than 5 years of age who seek medical care, according to a new study published in the New England Journal of Medicine.  Norovirus was responsible for nearly 1 million pediatric medical care visits for 2009 and 2010 in the United States, amounting to hundreds of millions of dollars in treatment costs each year.

 

“Infants and young children are very susceptible to norovirus infections, which often result in a high risk of getting dehydrated from the sudden onset of intense vomiting and severe diarrhea,” said Dr. Daniel Payne, an epidemiologist in the Division of Viral Diseases at the Centers for Disease Control and Prevention. “Our study estimates that 1 in 278 U.S. children will be hospitalized for norovirus illness by the time they turn 5 years of age. It is also estimated that about 1 in 14 children will visit an emergency room and 1 in 6 will receive outpatient care for norovirus infections.”

<SNIP>

 

“Our study confirmed that medical visits for rotavirus illness have decreased,” said Dr. Payne. “Also, our study reinforces the success of the U.S. rotavirus vaccination program and also emphasize the value of specific interventions to protect against norovirus illness.” Norovirus vaccines are currently being developed, which may be especially important for young children and elderly people who are high risk.

 

(Continue . . .)

 

 

 

Noroviruses, which are often mistakenly called `stomach flu’, are single-stranded RNA viruses that are able to evolve rapidly, so we typically see a new dominant norovirus strain emerge every two or three years. 

 

After exposure and a short incubation period (12-24 hours), the victim usually experiences nausea, frequent vomiting & diarrhea, and stomach pain – and may also experience headache, fever, and body aches.

 

The illness generally runs its course in 1 to 3 (very long) days, and most people recover. But among those who are aged or infirmed, the virus can take a heavy toll. According to the CDC, each year the norovirus:

 

  • causes about 21 million cases of acute gastroenteritis (inflammation of the stomach or intestines or both)
  • contributes to about 70,000 hospitalizations and 800 deaths, mostly among young children and the elderly

 

There are five genogroups (GI, GII, GIII, GIV, and GV) of noroviruses that can infect a variety of species, but  most human infections stem from genogroups GI and GII. GII noroviruses have at least 19 subtypes.

 

The most common cause of human illness is from Genogroup II, genotype 4 (abbreviated as GII.4).

 

In 2009, we saw the emergence of the New Orleans strain of GII.4, which had been the dominant strain for the past three years.

 

That is, until a new strain discovered a year ago by Professor Peter White and his team in the School of Biotechnology and Biomolecular Sciences in Australia (see UNSW: Sydney 2012 Norovirus Rising) - began to spread globally last fall.

 

In short order it was being reported in Japan, Taiwan, Europe, the UK, and North America (see Eurosurveillance: Emergence & Spread Of GII.4 Variant Norovirus).

 

According to a recent MMWR Report On New Norovirus GII.4 Sydney Strain, by December of 2012, the new Sydney strain was the cause of 58% of the norovirus outbreaks across the United States.

 

While reportedly `no worse’ than previous strains (which admittedly isn’t much comfort for those afflicted), levels of immunity to this emerging strain are exceedingly low, and it spreads like wildfire (see Vomiting Larry And His Aerosolized Norovirus).

 

Without a vaccine (yet) against Norovirus, prevention is key. 

 

One of the best preventatives is good hand hygiene, unfortunately, unlike with many other bacteria and viruses, alcohol gel doesn’t do a particularly good job of killing the virus (see CMAJ: Hand Sanitizers May Be `Suboptimal’ For Preventing Norovirus).

 

The CDC offers this advice to help prevent the spread of this virus.

image

Tuesday, March 23, 2010

FDA Calls For Temporary Halt To Using Rotarix Vaccine

 

 

# 4455

 

 

 

The `big’ news over the past 24 hours has been the  FDA’s recommendation that the use of GSK’s Rotarix rotavirus vaccine be temporarily suspended after it was discovered to be contaminated with DNA from a (probably harmless to humans) pig virus; Porcine circovirus 1 (PCV1)

 

Clinicians are advised to use Merck’s RotaTeq rotavirus vaccine pending a review of the GSK vaccine.

 

This is a complex story, and one that will take some time to sort out.  All of the facts are not in as yet, and the significance of this find are not at all clear.

 

Rotavirus is one of the leading causes of diarrheal illness in infants and young children, and is believed to cause the deaths of a half million children each year, mostly in developing countries.  

 

The vaccine, which became widely available in 2006, has been credited with a reduction in the incidence of rotavirus disease here in the US and in other countries (see MMWR Reduction in Rotavirus After Vaccine Introduction --- United States, 2000—2009).

 

 

Three pieces of information to help clarify the situation: 

 

First, a report by Maggie Fox of Reuters, one of the best science reporters in the business.

 

Second, the FDA  announcement.

 

And lastly, a referral to Vincent Racaniello’s Virology Blog, where he examines the problem.

 

Glaxo's rotavirus vaccine use suspended - US

12:00am EDT

 

* Merck vaccine not affected

* Suspension is temporary - no evidence of harm

* Rotavirus vaccines have troubled history (Adds WHO, European regulator comment)

 

By Maggie Fox, Health and Science Editor

WASHINGTON, March 22 (Reuters) - Doctors should temporarily stop using GlaxoSmithKline Plc's (GSK.L) (GSK.N) Rotarix vaccine against a diarrhea-causing virus called rotavirus because it is contaminated with an apparently harmless pig virus, regulators and the company said on Monday.

 

Doctors should instead give children Merck and Co Inc's (MRK.N) RotaTeq rotavirus vaccine, which is made using a different method and which shows no evidence of the virus, the U.S. Food and Drug Administration said.

 

The FDA and the company both found DNA from the virus in the vaccine. It is not clear whether whole virus is in the vaccine or just pieces of its DNA.

 

"We do believe the product is safe," FDA Commissioner Dr. Margaret Hamburg told reporters in a telephone briefing. Most children in the United States have been vaccinated with Merck's vaccine, which came onto the market sooner than Rotarix, she said.

(Continue . . .)

 

 

FDA NEWS RELEASE

For Immediate Release: March 22, 2010

Media Inquiries: Shelly Burgess, 301-796-4651; shelly.burgess@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk
FDA Recommends Clinicians Temporarily Suspend Use of Vaccine as Agency Learns More

FDA is recommending that healthcare practitioners temporarily suspend use of the Rotarix vaccine for rotavirus immunization in the United States while the agency learns more about components of an extraneous virus detected in the vaccine.  There is no evidence at this time that this finding poses a safety risk.

 

The agency recently became aware that an independent U.S. academic research team, using a novel technique, has found DNA from porcine circovirus 1 (PCV1) in Rotarix, which is manufactured by GlaxoSmithKline.  PCV1 is not known to cause illness in humans or other animals.  In addition, Rotarix has been studied extensively, before and after approval, and found to have an excellent safety record.

(Continue . . . )

 

 

And as a last stop, Vincent Racaniello takes a Virologist’s view of the story in:

 

Porcine circovirus DNA in rotavirus vaccine